Literature DB >> 21402769

Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis.

Gordon Y C Cheung1, Rong Wang, Burhan A Khan, Daniel E Sturdevant, Michael Otto.   

Abstract

The molecular basis underlying the pathogenic success of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is not completely understood, but differential gene expression has been suggested to account at least in part for the high virulence of CA-MRSA strains. Here, we show that the agr gene regulatory system has a crucial role in the development of skin infections in the most prevalent CA-MRSA strain USA300. Importantly, our data indicate that this is due to discrepancies between the agr regulon of CA-MRSA and those of hospital-associated MRSA and laboratory strains. In particular, agr regulation in strain USA300 led to exceptionally strong expression of toxins and exoenzymes, upregulation of fibrinogen-binding proteins, increased capacity to bind fibrinogen, and increased expression of methicillin resistance genes. Our findings demonstrate that agr functionality is critical for CA-MRSA disease and indicate that an adaptation of the agr regulon contributed to the evolution of highly pathogenic CA-MRSA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402769      PMCID: PMC3088142          DOI: 10.1128/IAI.00046-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Occurrence of the USA300 community-acquired Staphylococcus aureus clone in Austria.

Authors:  W Ruppitsch; A Stoger; D Schmid; R Fretz; A Indra; F Allerberger; W Witte
Journal:  Euro Surveill       Date:  2007-10-25

2.  Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Taeok Bae; Michael Otto; Frank R Deleo; Olaf Schneewind
Journal:  Nat Med       Date:  2007-12       Impact factor: 53.440

3.  Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006.

Authors:  Wolfgang Witte; Birgit Strommenger; Christa Cuny; Dagmar Heuck; Ulrich Nuebel
Journal:  J Antimicrob Chemother       Date:  2007-10-13       Impact factor: 5.790

4.  Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA.

Authors:  Rong Wang; Kevin R Braughton; Dorothee Kretschmer; Thanh-Huy L Bach; Shu Y Queck; Min Li; Adam D Kennedy; David W Dorward; Seymour J Klebanoff; Andreas Peschel; Frank R DeLeo; Michael Otto
Journal:  Nat Med       Date:  2007-11-11       Impact factor: 53.440

5.  Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification.

Authors:  Adam D Kennedy; Michael Otto; Kevin R Braughton; Adeline R Whitney; Liang Chen; Barun Mathema; Jose R Mediavilla; Kelly A Byrne; Larye D Parkins; Fred C Tenover; Barry N Kreiswirth; James M Musser; Frank R DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

6.  Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia.

Authors:  Christopher P Montgomery; Susan Boyle-Vavra; Patricia V Adem; Jean C Lee; Aliya N Husain; Julia Clasen; Robert S Daum
Journal:  J Infect Dis       Date:  2008-08-15       Impact factor: 5.226

7.  The antimicrobial peptide-sensing system aps of Staphylococcus aureus.

Authors:  Min Li; David J Cha; Yuping Lai; Amer E Villaruz; Daniel E Sturdevant; Michael Otto
Journal:  Mol Microbiol       Date:  2007-10-24       Impact factor: 3.501

8.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

9.  Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance.

Authors:  Matthew T G Holden; Edward J Feil; Jodi A Lindsay; Sharon J Peacock; Nicholas P J Day; Mark C Enright; Tim J Foster; Catrin E Moore; Laurence Hurst; Rebecca Atkin; Andrew Barron; Nathalie Bason; Stephen D Bentley; Carol Chillingworth; Tracey Chillingworth; Carol Churcher; Louise Clark; Craig Corton; Ann Cronin; Jon Doggett; Linda Dowd; Theresa Feltwell; Zahra Hance; Barbara Harris; Heidi Hauser; Simon Holroyd; Kay Jagels; Keith D James; Nicola Lennard; Alexandra Line; Rebecca Mayes; Sharon Moule; Karen Mungall; Douglas Ormond; Michael A Quail; Ester Rabbinowitsch; Kim Rutherford; Mandy Sanders; Sarah Sharp; Mark Simmonds; Kim Stevens; Sally Whitehead; Bart G Barrell; Brian G Spratt; Julian Parkhill
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-22       Impact factor: 11.205

10.  Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule.

Authors:  R P Novick; H F Ross; S J Projan; J Kornblum; B Kreiswirth; S Moghazeh
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598

View more
  147 in total

Review 1.  Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).

Authors:  Lance R Thurlow; Gauri S Joshi; Anthony R Richardson
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03-05

Review 2.  Staphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environments.

Authors:  Sana S Dastgheyb; Michael Otto
Journal:  Future Microbiol       Date:  2015-11-19       Impact factor: 3.165

3.  The virulence regulator Agr controls the staphylococcal capacity to activate human neutrophils via the formyl peptide receptor 2.

Authors:  Dorothee Kretschmer; Nele Nikola; Manuela Dürr; Michael Otto; Andreas Peschel
Journal:  J Innate Immun       Date:  2011-11-08       Impact factor: 7.349

Review 4.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

5.  ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation.

Authors:  Seth M Daly; Bradley O Elmore; Jeffrey S Kavanaugh; Kathleen D Triplett; Mario Figueroa; Huzefa A Raja; Tamam El-Elimat; Heidi A Crosby; Jon K Femling; Nadja B Cech; Alexander R Horswill; Nicholas H Oberlies; Pamela R Hall
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

6.  Early agr activation correlates with vancomycin treatment failure in multi-clonotype MRSA endovascular infections.

Authors:  Wessam Abdelhady; Liang Chen; Arnold S Bayer; Kati Seidl; Michael R Yeaman; Barry N Kreiswirth; Yan Q Xiong
Journal:  J Antimicrob Chemother       Date:  2015-01-05       Impact factor: 5.790

7.  Apicidin Attenuates MRSA Virulence through Quorum-Sensing Inhibition and Enhanced Host Defense.

Authors:  Corey P Parlet; Jeffrey S Kavanaugh; Heidi A Crosby; Huzefa A Raja; Tamam El-Elimat; Daniel A Todd; Cedric J Pearce; Nadja B Cech; Nicholas H Oberlies; Alexander R Horswill
Journal:  Cell Rep       Date:  2019-04-02       Impact factor: 9.423

8.  Staphylococcus aureus nuclease is an SaeRS-dependent virulence factor.

Authors:  Michael E Olson; Tyler K Nygaard; Laynez Ackermann; Robert L Watkins; Oliwia W Zurek; Kyler B Pallister; Shannon Griffith; Megan R Kiedrowski; Caralyn E Flack; Jeffrey S Kavanaugh; Barry N Kreiswirth; Alexander R Horswill; Jovanka M Voyich
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

9.  Global transcriptome analysis of Staphylococcus aureus biofilms in response to innate immune cells.

Authors:  Tyler D Scherr; Christelle M Roux; Mark L Hanke; Amanda Angle; Paul M Dunman; Tammy Kielian
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

10.  sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates.

Authors:  Agnieszka K Zielinska; Karen E Beenken; Lara N Mrak; Horace J Spencer; Ginell R Post; Robert A Skinner; Alan J Tackett; Alexander R Horswill; Mark S Smeltzer
Journal:  Mol Microbiol       Date:  2012-10-17       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.